Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
International Journal of Biological Sciences|May 11, 2022
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac InjurySi-Chi Xu, Wei Wu, Shu-Yang ZhangSignal Transduction and Targeted Therapy|March 15, 2023
Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implicationsSaiyang Xie, Si-Chi Xu, Wei Deng, et al.PPAR Research|April 26, 2016
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling PathwaysWen-Ying Wei, Zhen-Guo Ma, Si-Chi Xu, et al.Frontiers in Cardiovascular Medicine|August 15, 2022
Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized AnalysisSi-Chi Xu, Xin-Yue Zhao, Hai-Ping Xing, et al.PPAR Research|January 28, 2017
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and FibrosisSi-Chi Xu, Zhen-Guo Ma, Wen-Ying Wei, et al.Ebiomedicine|March 24, 2017
Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT PathwaysZhen-Guo Ma, Yu-Pei Yuan, Xin Zhang, et al.PPAR Research|January 15, 2020
Piperine Alleviates Doxorubicin-Induced Cardiotoxicity via Activating PPAR-γ in MiceJie Yan, Si-Chi Xu, Chun-Yan Kong, et al.Molecular and Cellular Endocrinology|April 16, 2018
Overexpression of CTRP3 protects against sepsis-induced myocardial dysfunction in miceWen-Ying Wei, Zhen-Guo Ma, Ning Zhang, et al.Cytokine|June 12, 2022
PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagyYing-Xian Liu, Yan-Jun Song, Xiao-Hang Liu, et al.Journal of Molecular and Cellular Cardiology|October 25, 2017
CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1Yu-Pei Yuan, Zhen-Guo Ma, Xin Zhang, et al.Pageof 3